Moderna's COVID-19 vaccine sales remain strong, quarterly revenue exceeds expectations
Special Topic: Focus on US Stock Q4 2025 Earnings Reports
Moderna announced on Friday that, thanks to better-than-expected sales of its COVID-19 vaccine in the United States, the company's fourth-quarter revenue exceeded Wall Street expectations.
This Cambridge, Massachusetts-based company, which earned huge profits during the pandemic, has been under financial pressure due to a sharp decline in demand for its COVID-19 vaccine. The company is developing new products to fill the revenue gap and demonstrate the long-term viability of its mRNA technology.
The company reiterated its expectation of achieving 10% revenue growth in 2026.
According to data compiled by LSEG, the vaccine maker's quarterly revenue was $678 million, while analysts on average had expected $626.1 million.
Editor: Guo Mingyu
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Gold recovers from YTD low, retakes $3,900; Fed hike bets and bullish USD to cap gains
Cerebras (CBRS.US) Cloud Business Soars, Masking Hardware Decline; OpenAI Supports Half of Cloud Revenue
Cerebras achieved record Q3 revenue, but hardware income dropped by nearly 30%, while cloud business accounted for two-thirds of total revenue. OpenAI contributed $72.4 million. The company raised its full-year guidance and expects Q4 to be close to breakeven.
Microsoft (MSFT.US) offers voluntary buyout packages to about 60,000 employees: Structural divergence in U.S. employment under AI transformation
In 2026, the U.S. labor market is characterized by both low layoffs and weak hiring. Companies like Microsoft and American Express are leveraging AI to optimize their workforce, while data centers are driving growth in the construction sector. However, entry-level white-collar jobs face increasing pressure, with real wages experiencing negative growth and structural transformation risks becoming more prominent.
Crypto prices
More
